Skip to main content

datastreet.in

Eli Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna

Eli Lilly ​will buy Orna Therapeutics for up to $2.4 billion in ⁠cash, gaining access to a technology that allows patients’ own cells to generate therapies inside the body, without the need to extract them.

Source :- Markets-Economic Times Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *